Life Spine gains FDA clearance for expanded indications of spine device

Alan Condon -   Print  |

The FDA on April 28 granted Life Spine 510(k) clearance to market implant and instrument additions to its ARx spinal system.

Three things to know:

1. ARx aims to improve the treatment of spinal deformity cases with a variety of spinal implants and instrumentation.

2. The device can be used with the Life Spine's Prolift expandable system and the Solstice OCT system, which provides stabilization and promotes fusion. 

3. ARx is Life Spine's fourth 510(k) clearance so far this year. The company has gained clearance for 92 devices since it was founded in 2002.

More articles on devices:
AAOS publishes clinical considerations for return to elective surgery
97% of medical practices suffer COVID-19 financial hit: 5 observations for orthopedics
Investor pays $49M for Arizona spine, orthopedic hospital property

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers